Literature DB >> 29263254

Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.

James A Williams1, Long Gui1,2, Nancy Hom1, Alexander Mileant1,2, Kelly K Lee3,2,4.   

Abstract

The neutralizing antibody (nAb) response against the influenza virus hemagglutinin (HA) fusion glycoprotein is important for preventing viral infection, but we lack a comprehensive understanding of the mechanisms by which these antibodies act. Here we investigated the effect of nAb binding and the role of IgG bivalency in the inhibition of HA function for nAbs targeting distinct HA epitopes. HC19 targets the receptor binding pocket at the distal end of HA, while FI6v3 binds primarily to the HA2 fusion subunit toward the base of the stalk. Surprisingly, HC19 inhibited the ability of HA to induce lipid mixing by preventing the structural rearrangement of HA under fusion-activating conditions. These results suggest that nAbs such as HC19 not only act by blocking receptor binding but also inhibit key late-stage HA conformational changes required for fusion. Intact HC19 IgG was also shown to cross-link separate virus particles, burying large proportions of HA within aggregates where they are blocked from interacting with target membranes; Fabs yielded no such aggregation and displayed weaker neutralization than IgG, emphasizing the impact of bivalency on the ability to neutralize virus. In contrast, the stem-targeting nAb FI6v3 did not aggregate particles. The Fab fragment was significantly less effective than IgG in preventing both membrane disruption and fusion. We infer that interspike cross-linking within a given particle by FI6v3 IgG may be critical to its potent neutralization, as no significant neutralization occurred with Fabs. These results demonstrate that IgG bivalency enhances HA inhibition through functionally important modes not evident in pared-down Fab-soluble HA structures.IMPORTANCE The influenza virus hemagglutinin (HA) fusion glycoprotein mediates entry into target cells and is the primary antigenic target of neutralizing antibodies (nAbs). Our current structural understanding of mechanisms of antibody (Ab)-mediated neutralization largely relies on the high-resolution characterization of antigen binding (Fab) fragments in complex with soluble, isolated antigen constructs by cryo-electron microscopy (EM) single-particle reconstruction or X-ray crystallography. Interactions between full-length IgG and whole virions have not been well characterized, and a gap remains in our understanding of how intact Abs neutralize virus and prevent infection. Using structural and biophysical approaches, we observed that Ab-mediated inhibition of HA function and neutralization of virus infectivity occur by multiple coexisting mechanisms, are largely dependent on the specific epitope that is targeted, and are highly dependent on the bivalent nature of IgG molecules.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  antibody; bivalency; electron microscopy; enveloped viruses; influenza; neutralization

Mesh:

Substances:

Year:  2018        PMID: 29263254      PMCID: PMC5827376          DOI: 10.1128/JVI.02006-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.

Authors:  M J Edwards; N J Dimmock
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

2.  Refined three-dimensional structure of the Fab fragment of a murine IgGl,lambda antibody.

Authors:  T Bizebard; R Daniels; R Kahn; B Golinelli-Pimpaneau; J J Skehel; M Knossow
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

Review 3.  Insights into neutralization of animal viruses gained from study of influenza virus.

Authors:  M C Outlaw; N J Dimmock
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

4.  Filamentous influenza virus enters cells via macropinocytosis.

Authors:  Jeremy S Rossman; George P Leser; Robert A Lamb
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

5.  Relationship between poliovirus neutralization and aggregation.

Authors:  A A Thomas; R Vrijsen; A Boeyé
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.

Authors:  Jason J Otterstrom; Boerries Brandenburg; Martin H Koldijk; Jarek Juraszek; Chan Tang; Samaneh Mashaghi; Ted Kwaks; Jaap Goudsmit; Ronald Vogels; Robert H E Friesen; Antoine M van Oijen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

7.  Electron cryotomography of measles virus reveals how matrix protein coats the ribonucleocapsid within intact virions.

Authors:  Lassi Liljeroos; Juha T Huiskonen; Ari Ora; Petri Susi; Sarah J Butcher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

8.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

9.  Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.

Authors:  P J Klasse
Journal:  Adv Biol       Date:  2014-09-09

10.  Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.

Authors:  T Danieli; S L Pelletier; Y I Henis; J M White
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

View more
  8 in total

1.  Stability of HA2 Prefusion Structure and pH-Induced Conformational Changes in the HA2 Domain of H3N2 Hemagglutinin.

Authors:  Micah W Eller; Hew Ming Helen Siaw; R Brian Dyer
Journal:  Biochemistry       Date:  2021-08-26       Impact factor: 3.162

Review 2.  New Biophysical Approaches Reveal the Dynamics and Mechanics of Type I Viral Fusion Machinery and Their Interplay with Membranes.

Authors:  Mark A Benhaim; Kelly K Lee
Journal:  Viruses       Date:  2020-04-08       Impact factor: 5.048

3.  Structural monitoring of a transient intermediate in the hemagglutinin fusion machinery on influenza virions.

Authors:  M A Benhaim; V Mangala Prasad; N K Garcia; M Guttman; K K Lee
Journal:  Sci Adv       Date:  2020-04-29       Impact factor: 14.136

Review 4.  Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.

Authors:  John R Gallagher; Dustin M McCraw; Udana Torian; Neetu M Gulati; Mallory L Myers; Michael T Conlon; Audray K Harris
Journal:  Vaccines (Basel)       Date:  2018-05-25

Review 5.  Viral Aggregation: The Knowns and Unknowns.

Authors:  Swechchha Pradhan; Arvind Varsani; Chloe Leff; Carter J Swanson; Rizal F Hariadi
Journal:  Viruses       Date:  2022-02-21       Impact factor: 5.048

6.  Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.

Authors:  Amanda L Skarlupka; Anne-Gaelle Bebin-Blackwell; Spencer F Sumner; Ted M Ross
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

7.  Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies.

Authors:  Ivan Kosik; Davide Angeletti; James S Gibbs; Matthew Angel; Kazuyo Takeda; Martina Kosikova; Vinod Nair; Heather D Hickman; Hang Xie; Christopher B Brooke; Jonathan W Yewdell
Journal:  J Exp Med       Date:  2019-01-25       Impact factor: 14.307

8.  Model-based inference of neutralizing antibody avidities against influenza virus.

Authors:  Janina Linnik; Mohammedyaseen Syedbasha; Yvonne Hollenstein; Jörg Halter; Adrian Egli; Jörg Stelling
Journal:  PLoS Pathog       Date:  2022-01-31       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.